Letter to MP and scrip pharma intelligence at informa15 Mar 2023 14:23
Letter to my MP Andrew Griffiths. Koolkat may not agree with my sentiments. How can we know of SAR presented a strong case if MHRA have not clarified what they want for over 4 months ?
My letter
Hi
I have been invested in a small biotechnology company called Sareum that is developing next generation treatments for cancer and autoimmune diseases. I have held a significant investment in the exciting products this company is developing for 12 years.
Today the company announced that they had been forced to set up an entity in Australia in order to be able to initiate and progress clinical trials on their lead product 1801 which offers therapeutics for a range of autoimmune diseases. The Company has been forced to do this because the MHRA (UK Medicines and Healthcare Regulatory Agency) have been unable to provide any further clarification to Sareum whatsoever subsequent to the MHRA's decision on 8th November to delay approval for clinical study and testing and request further information and review in order to approve of 1801. The MHRA advised Sareum in November that they required further information but in spite of requests from Sareum for details of what extra information is required the company has heard absolutely nothing.
Astra Zeneca and Glaxo have already expressed grave concerns and exasperation with the delays in processing approvals at MHRA and this episode with Sareum is just one more example of the utter ineptitude of the MHRA. Sareum, like other biopharma companies, are working tirelessly on vital research on life saving and life enhancing treatments and it as an absolute disgrace that this work is being hindered and delayed by the complete incompetence of a government agency.
I could barely believe my ears when the Chancellor referred to MHRA as one of the most respected health agencies in the world; does he have any idea what is actually happening on the ground and in the real world. It's frankly embarrassing. He proudly proclaimed the UK as a life science super power but how on earth can he make that ludicrous claim when the UK's main drug approval agency takes more than 4 months (and still waiting) to clarify what information it needs in order to approve a potential new treatment for clinical testing?
The Chancellor promised to speed up drug approvals by 2024 to achieve world leading status well it seems he has an awful lot of work to do to get this particular house in order.
In the meantime Australia, with their more efficient and streamlined clinical testing procedures, are likely to steal another potentially significant drug development away from the UK meaning more lost credibility and income for the UK. Not only is the UK, via MHRA, missing out on commercial trial activity but it is delaying vital regulatory approval of ground breaking and life changing drugs because of sheer incompetence.
The sooner this is resolved the better for the UK and for patients.